Mental Health
Comprehensive Mental Health Adherence Testing That Identifies What Is Not Seen Today
The challenges to mental health care posed by the pandemic are vast. In addition to significantly increased reports of anxiety and depression, and a sharp decrease in needed medical care, clinicians are seeing worsening mental health outcomes, increased substance use, and elevated suicidal ideation.¹
According to a recent survey, 41% of adults reported symptoms of anxiety and/or depressive disorder in January 2021 (a significant increase from the 11% reported during the same period in 2019) and 36% reported delaying or not getting the medical care they need because of the pandemic.² Additionally, 13% of adults reported new or increased substance use due to coronavirus-related stress, and 11% reported thoughts of suicide in the past 30 days.¹
¹https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a1.htm
²https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm
It is more important than ever that clinicians have insight into potentially high-risk patient behavior and non-adherence to their treatment plan.
Extensive Mental Health Test Menu
Navis Clinical offers an extensive drug testing menu with over 180 metabolites and parent drugs, with more than 60 mental health testing options.
INTEGRATED RESULTS MANAGEMENT REPORTS
Laboratory results management reports allow you to easily monitor your testing protocols, testing frequency and positivity trends to help you offer better care for your patients.
What are you missing?
An analysis of drug test results from mental health patients where medications were reported as prescribed revealed surprising insights:
65%
Demonstrated inconsistent results
38%
Tested negative for prescribed medications
19%
Tested positive for illicit drugs
32%
Tested positive for non-prescribed medications
Analysis of 17,720 samples from mental health patients where a medication was reported as prescribed with the test order; Jan 2018–Sept 2019
Medication non-adherence accounts for 30–50% of treatment failures.
Studies show that patients often overstate adherence because they fear disappointing their provider and that clinicians generally overestimate their own ability to identify and quantify non-adherence among their patients, highlighting the importance of objective and validated approaches to measurement, such as testing.
- Non-adherence to antipsychotic medications averages 42%
- Non-adherence to antidepressant medications averages 34%

Medication Matters: Causes and Solutions to Medication Non-Adherence National Council for Behavioral Health’s Medical Director Institute, September 2018